Status:

UNKNOWN

Effects of Individualized Cognitive Training on Cognition in Heart Failure

Lead Sponsor:

Louis Bherer

Collaborating Sponsors:

The Montreal Health Innovations Coordinating Center (MHICC)

Conditions:

Heart Failure

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The SYNAPSE trial is designed to study the effects of an individualized home-based cognitive training program on cognitive functions in heart-failure patients.

Detailed Description

The purpose of the SYNAPSE study is to evaluate the effects of an individualized home-based training program aimed to improve cognitive functions and well-being in heart failure patients. Heart failur...

Eligibility Criteria

Inclusion

  • Adult aged 50 or older
  • Have access to Internet
  • Have access to a computer or a tablet;
  • Have the ability to perform cognitive training;
  • Have the ability to read, understand and consent to the informed consent form;
  • Have chronic heart failure on tolerated therapy for at least two months;
  • Without limitation of physical activity to severe limitation of physical activity (i.e. NYHA class I, class II, class III OR class IV).

Exclusion

  • Acute cardiovascular event 1 month before randomization;
  • Cardiovascular procedure scheduled within 3 months;
  • Uncontrolled diabetes or untreated thyroid dysfunction;
  • Current or recent malignancy with a life expectancy of less than 1 year;
  • Neurological disease;
  • Chronic hemodialysis or peritoneal dialysis.

Key Trial Info

Start Date :

January 19 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2024

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT05223426

Start Date

January 19 2023

End Date

November 1 2024

Last Update

November 14 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Preventive medicine and physical activity center (centre EPIC), Montreal heart Institute

Montreal, Quebec, Canada, H1T1N6

2

Centre de recherche du centre Hospitalier de l'Université de Montréal (CRCHUM)

Montreal, Quebec, Canada